Deficient DNA mismatch repair testing, which is used for determining eligibility for PD-1/PD-L1 inhibitors, has been utilized for screening or as an auxiliary diagnostic method for Lynch syndrome. The gene discussed is CD274; the disease is Lynch syndrome.